Erasca (NASDAQ:ERAS – Free Report) had its price target cut by The Goldman Sachs Group from $7.00 to $4.00 in a research report sent to investors on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. Several other research analysts have also issued reports on ERAS. Capital One Financial reissued an […]
The Global Precision Oncology Market Size was Valued at USD 98.5 Billion in 2023 and the Worldwide Precision Oncology Market Size is Expected to Reach USD.
HC Wainwright Cuts Erasca (NASDAQ:ERAS) Price Target to $5.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Erasca, Inc. (NASDAQ:ERAS – Get Free Report) Director Alexander W. Casdin bought 80,000 shares of Erasca stock in a transaction that occurred on Tuesday, May 21st. The shares were acquired at an average cost of $2.27 per share, with a total value of $181,600.00. Following the acquisition, the director now owns 573,974 shares of the […]